Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vector-Borne Diseases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00595270
What this trial is testing

Long Term Persistence and Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51

Who this might be right for
Japanese Encephalitis
Valneva Austria GmbH 349
Early research (Phase 1)UnknownNCT02762045
What this trial is testing

Clinical Trial of Recombinant Adenovirus Type 5 AIDS Vaccine

Who this might be right for
Acquired Immunodeficiency Syndrome
Centers for Disease Control and Prevention, China 36
Post-approval studies (Phase 4)WithdrawnNCT01903057
What this trial is testing

Safety Study of Combined Azithromycin, Ivermectin and Albendazole for Trachoma and Lymphatic Filariasis

Who this might be right for
TrachomaLymphatic Filariasis
Emory University
Early research (Phase 1)Study completedNCT00513669
What this trial is testing

Phase Ib Trial of Two Virosome Formulated Malaria Vaccine Components (PEV 301, PEV 302) in Tanzania

Who this might be right for
Falciparum Malaria
Swiss Tropical & Public Health Institute 50
Testing effectiveness (Phase 2)Study completedNCT02909712
What this trial is testing

Cardiac Safety of Dihydroartemisinin-Piperaquine Amongst Pregnant Women in Tanzania

Who this might be right for
MalariaPregnancy MalariaCardiotoxicity+2 more
London School of Hygiene and Tropical Medicine 201
Large-scale testing (Phase 3)Study completedNCT00257530
What this trial is testing

Imiquimod Plus Antimony Immunochemotherapy for Cutaneous Leishmaniasis

Who this might be right for
Cutaneous Leishmaniasis
Drugs for Neglected Diseases 80
Post-approval studies (Phase 4)Study completedNCT00161967
What this trial is testing

TBE Antibody Persistence and Booster Vaccination Study in Children and Adolescents (Follow-up to Study 209)

Who this might be right for
Encephalitis, Tick-Borne
Pfizer 375
Post-approval studies (Phase 4)Study completedNCT02084602
What this trial is testing

Assessment of Artesunate/Mefloquine in the Peruvian Amazon

Who this might be right for
Malaria, Falciparum
Instituto Nacional de Salud. Peru 45
Testing effectiveness (Phase 2)Looking for participantsNCT06798402
What this trial is testing

Ciprofloxacin Intralesional Injection for the Treatment of Cutaneous Leishmaniasis Compared to Sodium Stibogluconate

Who this might be right for
Cutaneous Leishmaniasis
Al-Mustafa University College 80
Not applicableLooking for participantsNCT07389057
What this trial is testing

Assessing the Feasibility of Combining Dihydroartemisinin Piperaquine and Primaquine for Malaria Mass Drug Administration in High Endemic Communities in the Eastern Region of Ghana

Who this might be right for
Malaria Asymptomatic ParasitaemiaMalaria FalciparumMalaria Infection+1 more
Noguchi Memorial Institute for Medical Research 9,000
Early research (Phase 1)Study completedNCT01988636
What this trial is testing

Study of Safety and Effectiveness of Intravenous Immunization With PfSPZ Vaccine in Healthy African Adults

Who this might be right for
Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 296
Not applicableStudy completedNCT02793336
What this trial is testing

Early Life Cohort in Papua Indonesia (ELIPI Study)

Who this might be right for
Malaria
Menzies School of Health Research 500
Not applicableNot Yet RecruitingNCT07506967
What this trial is testing

Early Detection and AI-Based Management of Skin-Related Neglected Tropical Diseases in Sub-Saharan Africa by Frontline Health Workers

Who this might be right for
Skin and Connective Tissue DiseasesNeglected Tropical DiseasesLeprosy+10 more
Kenya Medical Research Institute 2,420
Not applicableStudy completedNCT00314899
What this trial is testing

Fetal Immunity to Falciparum Malaria

Who this might be right for
Plasmodium Falciparum Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 500
Large-scale testing (Phase 3)Study completedNCT02699099
What this trial is testing

Immunogenicity and Safety Study of GSK Biologicals' Candidate Malaria Vaccine Given at 6, 7.5 and 9 Months of Age in Co-administration With Measles, Rubella and Yellow Fever (YF) Vaccines Followed by a Booster of the Malaria Vaccine.

Who this might be right for
MalariaMalaria Vaccines
GlaxoSmithKline 699
Testing effectiveness (Phase 2)Study completedNCT01050907
What this trial is testing

Miltefosine to Treat Mucocutaneous Leishmaniasis

Who this might be right for
Mucosal LeishmaniasisCutaneous Leishmaniasis
Knight Therapeutics (USA) Inc 4
Post-approval studies (Phase 4)UnknownNCT01650792
What this trial is testing

Clinical Assessment, Neuroimaging and Immunomarkers in Chagas Disease Study (CLINICS)

Who this might be right for
Chagas Disease With Heart Failure
Federal University of Bahia 500
Large-scale testing (Phase 3)Study completedNCT00623857
What this trial is testing

Micronutrients and Child Health Study

Who this might be right for
Malaria
Wageningen University 612
Not applicableStudy completedNCT03631719
What this trial is testing

Impact of Wolbachia Deployment on Arboviral Disease Incidence in Medellin and Bello, Colombia

Who this might be right for
DengueChikungunya Virus InfectionZika Virus Infection
Universidad de Antioquia 834
Early research (Phase 1)Study completedNCT01288872
What this trial is testing

Praziquantel-Pharmacokinetic Study

Who this might be right for
Schistosomiasis
National Institute of Allergy and Infectious Diseases (NIAID) 47
Next Page